Microsoft Corporation vs Pfizer Inc.: Strategic Comparison
Key Differences at a Glance
| Field | Microsoft Corporation | Pfizer Inc. |
|---|---|---|
| Revenue | $281.7B | $62.6B |
| Founded | 1975 | 1849 |
| Employees | 228,000 | 75,000 |
| Market Cap | $2.96T | $148.0B |
| Headquarters | United States | United States |
Quick Stats Comparison
| Metric | Microsoft Corporation | Pfizer Inc. |
|---|---|---|
| Revenue | $281.7B | $62.6B |
| Founded | 1975 | 1849 |
| Headquarters | Redmond, Washington, United States | New York, New York |
| Market Cap | $2.96T | $148.0B |
| Employees | 228,000 | 75,000 |
Microsoft Corporation Revenue vs Pfizer Inc. Revenue — Year by Year
| Year | Microsoft Corporation | Pfizer Inc. | Leader |
|---|---|---|---|
| 2025 | $281.7B | $62.6B | Microsoft Corporation |
| 2024 | $245.1B | $63.6B | Microsoft Corporation |
| 2023 | $211.9B | $59.6B | Microsoft Corporation |
| 2022 | N/A | $101.2B | Pfizer Inc. |
| 2021 | N/A | $81.3B | Pfizer Inc. |
Business Model Breakdown
Overview: Microsoft Corporation vs Pfizer Inc.
This in-depth comparison examines Microsoft Corporation and Pfizer Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Microsoft Corporation on its own, evaluating Pfizer Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Microsoft Corporation and Pfizer Inc. is widest.
On the headline numbers, Microsoft Corporation reports annual revenue of $281.7B against $62.6B for Pfizer Inc., while their respective market capitalizations stand at $2.96T and $148.0B. Microsoft Corporation is headquartered in United States and Pfizer Inc. operates from United States, and those different home markets shape how each company competes.
Microsoft Corporation: Microsoft Corporation is a public company listed on NASDAQ under ticker MSFT. Microsoft makes money from cloud infrastructure, enterprise and consumer subscriptions, software licenses, Windows OEM and commercial licensing, LinkedIn, search and advertising, devices, gaming content, and developer platforms.
Pfizer Inc.: Pfizer has repeatedly reinvented itself around new therapeutic waves, from industrial fermentation and penicillin to Lipitor, vaccines, COVID products, and now oncology. The 2025 profile is not a pandemic windfall story; it is a large pharmaceutical company trying to rebuild a durable growth base.
Business Models: How Microsoft Corporation and Pfizer Inc. Make Money
Microsoft Corporation and Pfizer Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Microsoft Corporation and Pfizer Inc..
Microsoft Corporation business model: Microsoft makes money from cloud infrastructure, enterprise and consumer subscriptions, software licenses, Windows OEM and commercial licensing, LinkedIn, search and advertising, devices, gaming content, and developer platforms.
Pfizer Inc. business model: Pfizer makes money from patented prescription medicines, vaccines, oncology products, hospital therapies, rare disease products, collaborations, and global commercial distribution. Its economics depend on R&D success, regulatory approvals, patent protection, reimbursement, and lifecycle management.
Competitive Advantage: Microsoft Corporation vs Pfizer Inc.
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Microsoft Corporation stack up against those of Pfizer Inc..
Microsoft Corporation competitive advantage: Microsoft's advantage is enterprise distribution, Azure scale, Office workflows, Windows reach, developer tools, security products, LinkedIn, GitHub, and deep AI partnerships.
Pfizer Inc. competitive advantage: Pfizer advantage is scale: global regulatory expertise, manufacturing capacity, clinical development experience, commercial infrastructure, vaccine capabilities, and the ability to acquire or partner for scientific platforms.
Growth Strategy: Where Microsoft Corporation and Pfizer Inc. Are Headed
Future prospects matter as much as current results. The growth strategies below explain how Microsoft Corporation and Pfizer Inc. each plan to expand from here.
Microsoft Corporation growth strategy: Microsoft Corporation's growth strategy centers on this advantage: Microsoft's advantage is enterprise distribution, Azure scale, Office workflows, Windows reach, developer tools, security products, LinkedIn, GitHub, and deep AI partnerships.
Pfizer Inc. growth strategy: Pfizer growth strategy emphasizes oncology, vaccines, internal medicine, obesity and metabolic research, business development discipline, cost reduction, and global commercial execution. Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
Financial Picture: Microsoft Corporation vs Pfizer Inc.
A closer look at the financial trajectory of Microsoft Corporation and Pfizer Inc. rounds out the comparison.
Microsoft Corporation: Microsoft Corporation reported FY2025 revenue of $281.724B and net income of $101.832B.
Pfizer Inc.: Pfizer reported $62.579 billion of FY2025 revenue, compared with $63.627 billion in FY2024 and $59.553 billion in FY2023. Net income was $7.771 billion in FY2025. Pfizer employed approximately 75,000 people worldwide as of December 31, 2025.
Company-Specific SWOT Notes
Microsoft Corporation
Microsoft already sits inside enterprise identity, productivity, cloud, security, developer, and operating-system workflows.
AI and cloud capacity require large capital spending before every workload proves its long-term margin profile.
Copilots, Azure AI, GitHub, security, and business applications can turn installed-base reach into new recurring revenue.
Antitrust scrutiny, security incidents, hyperscaler competition, and platform shifts can slow growth or raise costs.
Pfizer Inc.
Pfizer has manufacturing, regulatory, clinical, and commercial infrastructure that few competitors can match globally.
Major products face loss of exclusivity and pricing pressure, requiring strong replacement revenue.
The Seagen acquisition gives Pfizer a larger oncology platform and ADC pipeline if clinical and commercial execution succeeds.
Medicare negotiation, generic competition, and failed pipeline readouts can compress revenue and margins.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | Microsoft Corporation | Microsoft Corporation reports the larger revenue base ($281.7B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | Pfizer Inc. | Founded in 1975 vs 1849. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | Microsoft Corporation | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | Microsoft Corporation | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | Microsoft Corporation | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
Microsoft Corporation reports the larger revenue base ($281.7B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1975 vs 1849. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: Microsoft Corporation or Pfizer Inc.?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: Microsoft Corporation vs Pfizer Inc.
Is Microsoft Corporation better than Pfizer Inc.?
Verdict: Between Microsoft Corporation and Pfizer Inc., Microsoft Corporation is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, Microsoft Corporation comes out ahead in this Microsoft Corporation vs Pfizer Inc. comparison.
Who earns more — Microsoft Corporation or Pfizer Inc.?
Microsoft Corporation earns more with $281.7B in annual revenue versus Pfizer Inc.'s $62.6B. Microsoft Corporation leads on total revenue based on latest verified figures.
Which company has higher revenue — Microsoft Corporation or Pfizer Inc.?
Microsoft Corporation reported $281.7B, while Pfizer Inc. reported $62.6B. The revenue leader is Microsoft Corporation based on latest verified figures.
Microsoft Corporation revenue vs Pfizer Inc. revenue — which is higher?
Microsoft Corporation revenue: $281.7B. Pfizer Inc. revenue: $62.6B. Microsoft Corporation has the larger revenue base of the two companies.
Sources & References
- SEC EDGAR: Microsoft Corporation Annual Filings (10-K, 8-K)
- Microsoft Corporation Corporate Website
- Microsoft Corporation Annual Report 2025 - Revenue and Financial Data
- sec.gov
- microsoft.com
- microsoft.com
- learn.microsoft.com
- news.microsoft.com
- blogs.microsoft.com
- SEC EDGAR: Pfizer Inc. Annual Filings (10-K, 8-K)
- Pfizer Inc. Corporate Website
- Pfizer Inc. Annual Report 2025 - Revenue and Financial Data
- sec.gov
- investors.pfizer.com
- pfizer.com
- investors.pfizer.com